Focus on additive series productionin the polymer sector

voxeljet AG and Evonik Industries— a multi-billion global leader in specialty chemicals, enter into a technology partnership to develop methods for series production of plastic components using 3D printing

voxeljet AG (NASDAQ: VJET) (the “Company”, or “voxeljet”), a leading OEM and provider of high-speed, large-format 3D printers and on-demand parts services to industrial and commercial customers, today announced a joint research and development partnership with Creavis- the strategic innovation unit of Evonik Industries, to develop methods for series production of plastic components using 3D printing.

Evonik and voxeljet have a long-standing cooperation, particularly in the development of polymer powders for voxeljet’s binder jetting processes. In order to expand the portfolio of materials for 3D printing of plastic parts, the two companies have decided to intensify their cooperation.

“In Evonik, we have found an excellent partner who provides us with customized material systems for our 3D printing technology. This research collaboration is intended to enhance our efforts in the 3D printing of polymers for series production,” says Dr. Ingo Ederer, CEO of voxeljet.

The joint research project combines Evonik’s many years of experience in polymer powders for additive manufacturing technologies with voxeljet’s 20 years of expertise in industrial 3D printing.

“voxeljet is one of the leading manufacturers of large-format, high-speed 3D printers. Together, we aim to develop new powder-binder systems which allow the 3D printing of polymer components with industrial utility”, says Prof. Dr. Stefan Buchholz, Managing Director of Evonik Creavis GmbH.

Evonik will provide insights into their research work on binder jetting developments for additive manufacturing at the formnext show, the international exhibition and conference on the next generation of manufacturing technologies in Frankfurt, Germany Hall 12.1, Booth C71, from November 19 to 22, 2019.

Evonik is one of the world leaders in specialty chemicals. The focus on more specialty businesses, customer-oriented innovative prowess and a trustful and performance-oriented corporate culture form the heart of Evonik’s corporate strategy. They are the lever for profitable growth and a sustained increase in the value of the company. Evonik benefits specifically from its customer proximity and leading market positions. Evonik is active in over 100 countries around the world. In fiscal 2018, the enterprise with more than 32,000 employees generated sales of €13.3 billion and an operating profit (adjusted EBITDA) of €2.15 billion from continuing operations. corporate.evonik.com